An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia. Drugs 41 (1991): 596-624
Enhances sort-duration, high-intensity physical performance
VLEKT is characterized by a very low total energy intake (650800 kcal per day), carbohydrate restriction to less than 30 g/day, fat intake of around 20 g/day with a preference for sources of unsaturated fats such as extra-virgin olive oil, and protein intake of 0.81.2 g/kg of reference body weight (i.e., calculated based on the patient's height) ( MAD was developed in 2003 as an alternative to the conventional KD, particularly in the context of treating drug-resistant epilepsy ( MCTKD was developed in 1971 by Huttenlocher et al
Scientists are now exploring combinations of copper peptides with stem-cell extracts, nanotechnology delivery systems, and bio-identical growth factors to maximise absorption and results
We used Image J ( and the Leica software to analyze the data
.png)
